139 related articles for article (PubMed ID: 32336626)
1. Importance of patient reported and clinical outcomes for patients with locally advanced rectal cancer and their treating physicians. Do clinicians know what patients want?
van der Valk MJM; van der Sande ME; Toebes RE; Breukink SO; Bröker MEE; Doornebosch PG; Maliko N; Neijenhuis PA; Marinelli AWKS; Peters FP; Peeters KCMJ; Beets GL; Marang-van de Mheen PJ; Hilling DE
Eur J Surg Oncol; 2020 Sep; 46(9):1634-1641. PubMed ID: 32336626
[TBL] [Abstract][Full Text] [Related]
2. Preferences for outcomes of treatment for rectal cancer: patient and clinician utilities and their application in an interactive computer-based decision aid.
Masya LM; Young JM; Solomon MJ; Harrison JD; Dennis RJ; Salkeld GP
Dis Colon Rectum; 2009 Dec; 52(12):1994-2002. PubMed ID: 19934920
[TBL] [Abstract][Full Text] [Related]
3. Quality of life after rectal-preserving treatment of rectal cancer.
Jones HJS; Al-Najami I; Cunningham C
Eur J Surg Oncol; 2020 Nov; 46(11):2050-2056. PubMed ID: 32773139
[TBL] [Abstract][Full Text] [Related]
4. Functional Outcomes and Health-Related Quality of Life After Curative Treatment for Rectal Cancer: A Population-Level Study in England.
Downing A; Glaser AW; Finan PJ; Wright P; Thomas JD; Gilbert A; Corner J; Richards M; Morris EJA; Sebag-Montefiore D
Int J Radiat Oncol Biol Phys; 2019 Apr; 103(5):1132-1142. PubMed ID: 30553942
[TBL] [Abstract][Full Text] [Related]
5. Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis.
Renehan AG; Malcomson L; Emsley R; Gollins S; Maw A; Myint AS; Rooney PS; Susnerwala S; Blower A; Saunders MP; Wilson MS; Scott N; O'Dwyer ST
Lancet Oncol; 2016 Feb; 17(2):174-183. PubMed ID: 26705854
[TBL] [Abstract][Full Text] [Related]
6. Patient preferences for palliative treatment of locally advanced or metastatic gastric cancer and adenocarcinoma of the gastroesophageal junction: a choice-based conjoint analysis study from Germany.
Hofheinz R; Clouth J; Borchardt-Wagner J; Wagner U; Weidling E; Jen MH; Brück P
BMC Cancer; 2016 Dec; 16(1):937. PubMed ID: 27923357
[TBL] [Abstract][Full Text] [Related]
7. Late patient-reported toxicity after preoperative radiotherapy or chemoradiotherapy in nonresectable rectal cancer: results from a randomized Phase III study.
Brændengen M; Tveit KM; Bruheim K; Cvancarova M; Berglund Å; Glimelius B
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1017-24. PubMed ID: 20932687
[TBL] [Abstract][Full Text] [Related]
8. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
[No Abstract] [Full Text] [Related]
9. Quality of Life and Functional Outcome After Transanal Abdominal Transanal Proctectomy for Low Rectal Cancer.
Marks JH; Salem JF; Valsdottir EB; Yarandi SS; Marks GJ
Dis Colon Rectum; 2017 Mar; 60(3):258-265. PubMed ID: 28177987
[TBL] [Abstract][Full Text] [Related]
10. Patient Preferences and Urologist Judgments on Prostate Cancer Therapy in Japan.
Nakayama M; Kobayashi H; Okazaki M; Imanaka K; Yoshizawa K; Mahlich J
Am J Mens Health; 2018 Jul; 12(4):1094-1101. PubMed ID: 29774804
[TBL] [Abstract][Full Text] [Related]
11. Effect of Neoadjuvant Therapy and Rectal Surgery on Health-related Quality of Life in Patients With Rectal Cancer During the First 2 Years After Diagnosis.
Couwenberg AM; Burbach JPM; van Grevenstein WMU; Smits AB; Consten ECJ; Schiphorst AHW; Wijffels NAT; Heikens JT; Intven MPW; Verkooijen HM
Clin Colorectal Cancer; 2018 Sep; 17(3):e499-e512. PubMed ID: 29678514
[TBL] [Abstract][Full Text] [Related]
12. Impact of functional results on quality of life after rectal cancer surgery.
Vironen JH; Kairaluoma M; Aalto AM; Kellokumpu IH
Dis Colon Rectum; 2006 May; 49(5):568-78. PubMed ID: 16583289
[TBL] [Abstract][Full Text] [Related]
13. Methodologic evaluation of adaptive conjoint analysis to assess patient preferences: an application in oncology.
Pieterse AH; Stiggelbout AM; Marijnen CA
Health Expect; 2010 Dec; 13(4):392-405. PubMed ID: 20550594
[TBL] [Abstract][Full Text] [Related]
14. ["Watch and wait" strategy after neoadjuvant therapy for rectal cancer: status survey of perceptions, attitudes and treatment selection in Chinese surgeons].
Sun TT; Wang L; Yao YF; Peng YF; Zhao J; Zhan TC; Leng JH; Wang HY; Chen N; Chen PJ; Li YJ; Zhang X; Liu XZ; Zhang Y; Wu AW
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):550-559. PubMed ID: 31238634
[No Abstract] [Full Text] [Related]
15. Benefit from preoperative radiotherapy in rectal cancer treatment: disease-free patients' and oncologists' preferences.
Pieterse AH; Stiggelbout AM; Baas-Thijssen MC; van de Velde CJ; Marijnen CA
Br J Cancer; 2007 Sep; 97(6):717-24. PubMed ID: 17848910
[TBL] [Abstract][Full Text] [Related]
16. Oncological Outcomes and Hospital Costs of the Treatment in Patients With Rectal Cancer: Watch-and-Wait Policy and Standard Surgical Treatment.
Hupkens BJP; Breukink SO; Stoot JHMB; Toebes RE; van der Sande ME; Melenhorst J; Beets GL; Dirksen CD
Dis Colon Rectum; 2020 May; 63(5):598-605. PubMed ID: 32032202
[TBL] [Abstract][Full Text] [Related]
17. Importance of patient reported outcome measures versus clinical outcomes for breast cancer patients evaluation on quality of care.
Kool M; van der Sijp JR; Kroep JR; Liefers GJ; Jannink I; Guicherit OR; Vree R; Bastiaannet E; van de Velde CJ; Marang-van de Mheen PJ
Breast; 2016 Jun; 27():62-8. PubMed ID: 27026219
[TBL] [Abstract][Full Text] [Related]
18. What do patients want? Patient preferences and surrogate decision making in the treatment of colorectal cancer.
Solomon MJ; Pager CK; Keshava A; Findlay M; Butow P; Salkeld GP; Roberts R
Dis Colon Rectum; 2003 Oct; 46(10):1351-7. PubMed ID: 14530674
[TBL] [Abstract][Full Text] [Related]
19. Patient explicit consideration of tradeoffs in decision making about rectal cancer treatment: benefits for decision process and quality of life.
Pieterse AH; Kunneman M; van den Hout WB; Baas-Thijssen M; Geijsen ED; Ceha HM; Muller KM; van der Linden YM; Marijnen CAM; Stiggelbout AM
Acta Oncol; 2019 Jul; 58(7):1069-1076. PubMed ID: 30971150
[No Abstract] [Full Text] [Related]
20. Tolerability, Safety, and Outcomes of Neoadjuvant Chemoradiotherapy With Capecitabine for Patients Aged ≥ 70 Years With Locally Advanced Rectal Cancer.
Jacobs L; van der Vlies E; Ten Bokkel Huinink D; Bloemendal H; Intven M; Smits AB; Weusten BLAM; Siersema PD; van Lelyveld N; Los M
Clin Colorectal Cancer; 2018 Sep; 17(3):179-186. PubMed ID: 29661620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
